Solventum (NYSE:SOLV – Get Free Report) is one of 238 public companies in the “Surgical & medical instruments” industry, but how does it contrast to its rivals? We will compare Solventum to related ...

Solventum has been treading water for the past six months, recording a small return of 2.6% while holding steady at $74.01.

Solventum announced a strategic partnership with SprintRay to deliver disruptive 3D printing for dental technologies.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Solventum, the 3M healthcare spinoff, eliminated 800 positions as part of a restructuring strategy to help fuel growth. CEO Bryan Hanson, in an investor day presentation last week, said the ...

Shares of Solventum Corp. SOLV rallied 1.71% to $75.51 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.33% to 5,693.31 ...

Solventum Dental Solutions connects leading-edge materials with data science to help dentists solve their toughest challenges with products such as Filtek™ Easy Match Universal Restorative ...

Solventum detailed its 2025-2028 growth strategy, reaffirmed its 2025 guidance, and reported Q4 earnings that topped expectations with strong sales and EPS.

ST. PAUL, Minn., March 20, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today hosts its 2025 Investor Day and will outline strategic priorities for the Company, its business segments, and its long ...

Solventum and SprintRay enter dental 3D printing partnership - to produce chairside 3D printed crowns, inlays, onlays, and ...

In this first-of-its-kind partnership for its Dental Solutions business, Solventum, formerly 3M Health Care, is striving to ...

"Together, we can make a significant impact in restorative dentistry by building exceptional products for same-visit treatment," said SprintRay CEO Amir Mansouri. "Our partnership with Solventum ...